Kelly S G Aminian1, Antonio P Strafella. 1. Morton and Gloria Shulman Movement Disorder Unit & E.J. Safra Parkinson Disease Program, Toronto Western Hospital, UHN, Toronto, Ontario, Canada.
Abstract
PURPOSE OF REVIEW: This review explores recent literature pertaining to affective disorders associated with Parkinson's disease. RECENT FINDINGS: Nonmotor symptoms including affective disorders are becoming more widely recognized as complications of Parkinson's disease. As awareness of these symptoms increases, and new neuroimaging tools are developed and become more accessible, more studies are being conducted pertaining to behavioral complications in Parkinson's disease. The functional connectivity of the basal ganglia can predispose people with Parkinson's to develop affective disorders. Furthermore, dopaminergic treatments may exacerbate or trigger behavioral symptoms. It is now understood that changes associated with Parkinson's disease are widespread, affecting striatal and extrastriatal regions and resulting in alterations in gray matter, white matter, blood flow, metabolism, and dopaminergic and serotonergic function. SUMMARY: Neuroimaging is advancing our knowledge of the mechanisms involved in Parkinson's disease, and their role in the development of behavioral disorders. An increased understanding of these disorders may lead to the discovery of new therapeutic targets, or the identification of risk factors for the development of these disorders. If preventive therapies become available, identification of risk factors will be important for the identification and treatment of susceptible individuals.
PURPOSE OF REVIEW: This review explores recent literature pertaining to affective disorders associated with Parkinson's disease. RECENT FINDINGS: Nonmotor symptoms including affective disorders are becoming more widely recognized as complications of Parkinson's disease. As awareness of these symptoms increases, and new neuroimaging tools are developed and become more accessible, more studies are being conducted pertaining to behavioral complications in Parkinson's disease. The functional connectivity of the basal ganglia can predispose people with Parkinson's to develop affective disorders. Furthermore, dopaminergic treatments may exacerbate or trigger behavioral symptoms. It is now understood that changes associated with Parkinson's disease are widespread, affecting striatal and extrastriatal regions and resulting in alterations in gray matter, white matter, blood flow, metabolism, and dopaminergic and serotonergic function. SUMMARY: Neuroimaging is advancing our knowledge of the mechanisms involved in Parkinson's disease, and their role in the development of behavioral disorders. An increased understanding of these disorders may lead to the discovery of new therapeutic targets, or the identification of risk factors for the development of these disorders. If preventive therapies become available, identification of risk factors will be important for the identification and treatment of susceptible individuals.
Authors: Daniel Weintraub; Juergen Koester; Marc N Potenza; Andrew D Siderowf; Mark Stacy; Valerie Voon; Jacqueline Whetteckey; Glen R Wunderlich; Anthony E Lang Journal: Arch Neurol Date: 2010-05
Authors: Roberto Cilia; Ji Hyun Ko; Sang Soo Cho; Thilo van Eimeren; Giorgio Marotta; Giovanna Pellecchia; Gianni Pezzoli; Angelo Antonini; Antonio P Strafella Journal: Neurobiol Dis Date: 2010-03-22 Impact factor: 5.996
Authors: Anne Marthe Meppelink; Bauke M de Jong; Remco Renken; Klaus L Leenders; Frans W Cornelissen; Teus van Laar Journal: Brain Date: 2009-09-15 Impact factor: 13.501
Authors: Benedicte Ballanger; Antonio P Strafella; Thilo van Eimeren; Mateusz Zurowski; Pablo M Rusjan; Sylvain Houle; Susan H Fox Journal: Arch Neurol Date: 2010-04
Authors: Andre C Felicio; Tais S Moriyama; Clecio Godeiro-Junior; Ming C Shih; Marcelo Q Hoexter; Vanderci Borges; Sonia M A Silva; Edson Amaro-Junior; Luiz A F Andrade; Henrique B Ferraz; Rodrigo A Bressan Journal: Psychopharmacology (Berl) Date: 2010-05-22 Impact factor: 4.530
Authors: Jennifer S A M Reijnders; Bart Scholtissen; Wim E J Weber; Pauline Aalten; Frans R J Verhey; Albert F G Leentjens Journal: Mov Disord Date: 2010-10-30 Impact factor: 10.338
Authors: F Le Jeune; D Drapier; A Bourguignon; J Péron; H Mesbah; S Drapier; P Sauleau; C Haegelen; D Travers; E Garin; C H Malbert; B Millet; M Vérin Journal: Neurology Date: 2009-11-24 Impact factor: 9.910